These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20724167)

  • 1. Insights into MAPK p38alpha DFG flip mechanism by accelerated molecular dynamics.
    Filomia F; De Rienzo F; Menziani MC
    Bioorg Med Chem; 2010 Sep; 18(18):6805-12. PubMed ID: 20724167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state.
    Bukhtiyarova M; Karpusas M; Northrop K; Namboodiri HV; Springman EB
    Biochemistry; 2007 May; 46(19):5687-96. PubMed ID: 17441692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human p38α mitogen-activated protein kinase in the Asp168-Phe169-Gly170-in (DFG-in) state can bind allosteric inhibitor Doramapimod.
    Suplatov D; Kopylov K; Sharapova Y; Švedas V
    J Biomol Struct Dyn; 2019 May; 37(8):2049-2060. PubMed ID: 29749295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase in motion: insights into the dynamic nature of p38α by high-pressure NMR spectroscopic studies.
    Nielsen G; Jonker HR; Vajpai N; Grzesiek S; Schwalbe H
    Chembiochem; 2013 Sep; 14(14):1799-806. PubMed ID: 23843149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
    Badrinarayan P; Sastry GN
    J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase.
    Yang Y; Shen Y; Liu H; Yao X
    J Chem Inf Model; 2011 Dec; 51(12):3235-46. PubMed ID: 22097958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active mutants of the TCR-mediated p38α alternative activation site show changes in the phosphorylation lip and DEF site formation.
    Tzarum N; Diskin R; Engelberg D; Livnah O
    J Mol Biol; 2011 Feb; 405(5):1154-69. PubMed ID: 21146537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence, structure, and active site analyses of p38 MAP kinase: exploiting DFG-out conformation as a strategy to design new type II leads.
    Badrinarayan P; Sastry GN
    J Chem Inf Model; 2011 Jan; 51(1):115-29. PubMed ID: 21141877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
    Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38γ activation triggers dynamical changes in allosteric docking sites.
    Rodriguez Limardo RG; Ferreiro DN; Roitberg AE; Marti MA; Turjanski AG
    Biochemistry; 2011 Mar; 50(8):1384-95. PubMed ID: 21235211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitors.
    Liu H; Kuhn C; Feru F; Jacques SL; Deshmukh GD; Ye P; Rennie GR; Johnson T; Kazmirski S; Low S; Coli R; Ding YH; Cheng AC; Tecle H; English JM; Stanton R; Wu JC
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4885-91. PubMed ID: 20620059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring protein kinase conformation using swarm-enhanced sampling molecular dynamics.
    Atzori A; Bruce NJ; Burusco KK; Wroblowski B; Bonnet P; Bryce RA
    J Chem Inf Model; 2014 Oct; 54(10):2764-75. PubMed ID: 25178116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid molecules induce p38α activation via a novel molecular switch.
    Tzarum N; Eisenberg-Domovich Y; Gills JJ; Dennis PA; Livnah O
    J Mol Biol; 2012 Dec; 424(5):339-53. PubMed ID: 23079240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
    Vijayan RS; He P; Modi V; Duong-Ly KC; Ma H; Peterson JR; Dunbrack RL; Levy RM
    J Med Chem; 2015 Jan; 58(1):466-79. PubMed ID: 25478866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Small Molecule Binding Pockets in p38α MAP Kinase.
    Gomez-Gutierrez P; Rubio-Martinez J; Perez JJ
    J Chem Inf Model; 2017 Oct; 57(10):2566-2574. PubMed ID: 28872880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib.
    Yan M; Wang H; Wang Q; Zhang Z; Zhang C
    Phys Chem Chem Phys; 2016 Apr; 18(15):10367-74. PubMed ID: 27029952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations.
    Simard JR; Getlik M; Grütter C; Schneider R; Wulfert S; Rauh D
    J Am Chem Soc; 2010 Mar; 132(12):4152-60. PubMed ID: 20201574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase.
    Frembgen-Kesner T; Elcock AH
    J Mol Biol; 2006 May; 359(1):202-14. PubMed ID: 16616932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A turning point in the knowledge of the structure-function-activity relations of elastin].
    Alix AJ
    J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.